Bisphosphonates and phossy-jaw: breathing new life into an old problem

被引:13
作者
Ashcroft, John [1 ]
机构
[1] Mid Yorkshire Hosp NHS Trust, Pinderfields Hosp, Wakefield, Yorks, England
关键词
D O I
10.1016/S1470-2045(06)70704-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
引用
收藏
页码:447 / 449
页数:3
相关论文
共 8 条
[1]
Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors [J].
Badros, A ;
Weikel, D ;
Salama, A ;
Goloubeva, O ;
Schneider, A ;
Rapoport, A ;
Fenton, R ;
Gahres, N ;
Sausville, E ;
Ord, R ;
Meiller, T .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (06) :945-952
[2]
A study of the biological receptor activator of nuclear factor-κB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer [J].
Body, JJ ;
Facon, T ;
Coleman, RE ;
Lipton, A ;
Geurs, F ;
Fan, M ;
Holloway, D ;
Peterson, MC ;
Bekker, P .
CLINICAL CANCER RESEARCH, 2006, 12 (04) :1221-1228
[3]
Anti-tumour activity of zoledronic acid [J].
Clézardin, P .
CANCER TREATMENT REVIEWS, 2005, 31 :S1-S8
[4]
Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment [J].
Marx, RE ;
Sawatari, Y ;
Fortin, M ;
Broumand, V .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2005, 63 (11) :1567-1575
[6]
The clinical and cost considerations of bisphosphonates in preventing bone complications in patients with metastatic breast cancer or multiple myeloma [J].
McCloskey, EV ;
Guest, JF ;
Kanis, JA .
DRUGS, 2001, 61 (09) :1253-1274
[7]
Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment [J].
Migliorati, Cesar A. ;
Siegel, Michael A. ;
Elting, Linda S. .
LANCET ONCOLOGY, 2006, 7 (06) :508-514
[8]
Guidelines on the diagnosis and management of multiple myeloma 2005 [J].
Smith, A ;
Wisloff, F ;
Samson, D .
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 132 (04) :410-451